It is well established that Paxil carries a risk of suicide in children and teens. Nonetheless, GlaxoSmithKline has been conducting a study of the antidepressant using children as young as seven.
The drug carries a “black box” stating that it is twice as likely to generate lethal thoughts as a placebo.